Profiles

Elliot Frohman

Distinguished Senior Fellow (Sabbatical) Stanford University School of Medicine

Verified email at austin.utexas.edu

Cited by 30586

Neuroimmunology Molecular Immunology Neuro-Ophthalmology Neuro-Infectious Diseases Neurotherapeutics

Viness Pillay

University of the Witwatersrand

Verified email at wits.ac.za

Cited by 17428

Biomaterials Advanced Drug Delivery Atomistic Simulations Implant Neurotherapeutics

Harris A Gelbard

Professor of Neurology, University of Rochester Medical Center

Verified email at urmc.rochester.edu

Cited by 13512

Neurotherapeutics Neuroscience Immunology

Bobby Thomas

Professor

Verified email at musc.edu

Cited by 9964

Neurodegeneration Neurotherapeutics mitochondrial dysfunction oxidative stress neuroinflammation

Lars Wahlberg

CEO/CMO - Sinfonia Biotherapeutics

Verified email at sinfoniabtx.com

Cited by 5564

Neurotherapeutics Neurodegeneration

Marc Louis Copersino, PhD ABPP-CP

Clinical Psychologist and Assistant Professor of Psychology, Harvard Medical School

Verified email at mclean.harvard.edu

Cited by 3809

Addiction Substance Use Disorders Mood Disorders Neurodevelopmental Disorders Neurotherapeutics

Jianxiong Jiang

University of Tennessee College of Pharmacy

Verified email at uthsc.edu

Cited by 3501

Pharmacology Neuroscience Neurotherapeutics

Kevin C. Chan

NeuroImaging and Visual Science Laboratory, New York University Grossman School of …

Verified email at nyumc.org

Cited by 3426

Biomedical imaging / MRI Visual System Glaucoma Neurotherapeutics Sensory Substitution

Jonathan Nassi

Senior Director of Translational Science, Inscopix Inc.

Verified email at inscopix.com

Cited by 2830

Neuroscience Neurotech Neurotherapeutics

Raghavendra Gowda MS, PhD

Senior Advisor, Toxicology, Eli Lilly & Company (Gene Therapy)

Cited by 2801

Caner Therapeutics Neurotherapeutics Toxicology Pharmacology

1 - 10